Old Web
English
Sign In
Acemap
>
authorDetail
>
Michel Famelart
Michel Famelart
UCB
Biochemistry
Pharmacology
Chemistry
Catechol-O-Methyltransferase Inhibitors
Potency
3
Papers
80
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-Methyltransferase
2016
Journal of Biomolecular Screening
Martha Kimos
Maggi Burton
David Urbain
Didier Caudron
Murielle Martini
Michel Famelart
Michel Gillard
James C. Barrow
Martyn D. Wood
Show All
Source
Cite
Save
Citations (14)
Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.
2013
British Journal of Pharmacology
A Mingorance‐Le Meur
Philippe Ghisdal
Brice Mullier
P. De Ron
P. Downey
C Van Der Perren
V Declercq
S Cornelis
Michel Famelart
J. van Asperen
Eric Jnoff
Jean-Philippe Courade
Show All
Source
Cite
Save
Citations (36)
Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP-2)
2012
CNS Neuroscience & Therapeutics
Christian Wolff
Bruce Carrington
Michel Varrin-Doyer
Anne Vandendriessche
Christy Van der Perren
Michel Famelart
Michel Gillard
Patrik Foerch
Véronique Rogemond
Jérôme Honnorat
Alastair David Griffiths Lawson
Karen Margrete Miller
Show All
Source
Cite
Save
Citations (30)
1